Purchase Order 75N98026P00380
Award Date 4/30/26
Potential Completion Date 4/29/27
Potential Value $18K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Portage, MI 49002, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for allergy testing services. The contract is a Blanket Purchase Agreement (BPA) call with a firm-fixed price ceiling value of $24,960.42 and a performance period through September 30, 2025. Phadia US Inc. specializes in providing advanced allergy and autoimmune testing solutions to federal government agencies, primarily through the supply of its IMMUNOCAP SYSTEM ANALYZERS...
- The Defense Health Agency awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $49,732.62 to Phadia US Inc.'s Immunodiagnostics Division on December 4, 2025, for allergy testing services that provide critical information in the detection and management of allergic reactions. The contract, which is set to be completed by September 30, 2026, will be performed in Portage, Michigan. As a subsidiary of Thermo Fisher Scientific specializing in advanced allergy and autoimmune...
- This is a federal contract award to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, to provide reagents required for allergy testing. The contract is a Blanket Purchase Agreement (BPA) Call with the Defense Health Agency, a defense agency, with a ceiling value of $24,960.42 and a completion date of September 30, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation. Phadia US Inc. is a foreign-owned, for-profit organization that specializes in...
- This is a firm fixed-price purchase order contract awarded by the Department of the Army Medical Command to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the delivery of $146,363.76 in allergen detection equipment and reagents. Phadia is a provider of allergy and autoimmune testing solutions, and has previously supplied allergy testing analyzers, reagents, and associated consumables to Department of Defense health agencies and facilities to support their medical readiness...
- The Defense Health Agency awarded a $79,572.42 firm fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 21, 2026, for reagent testing supplies to support allergic reaction detection and management at a military medical treatment facility in Portage, Michigan. The contract is scheduled for completion by September 30, 2026, and was awarded through open market procurement without set-aside designation. Phadia US Inc., a foreign-owned...
- This is a firm-fixed-price contract awarded by the Defense Health Agency to Phadia US Inc., a subsidiary of Thermo Fisher Scientific, for the manufacture of in-vitro diagnostic substances. The $24,960.42 contract has a period of performance through September 30, 2025 and was awarded on June 17, 2025 without a set-aside designation. Phadia US Inc. specializes in advanced allergy and autoimmune testing solutions, providing IMMUNOCAP SYSTEM ANALYZERS and related equipment, software, supplies,...
- This is a $3,332,143.51 definitive, firm-fixed-price federal contract awarded by the Department of the Army Medical Command to Phadia US Inc. Immunodiagnostics Division, a subsidiary of Thermo Fisher Scientific. The contract is for the provision of allergy testing equipment, reagents, and associated consumables to support the military's medical readiness mission. Phadia has previously provided similar allergy testing products and services to other Department of Defense health agencies and...
- The Defense Health Agency awarded a $20,580 firm-fixed-price Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on August 26, 2025, with completion targeted for September 30, 2025. This contract procures allergen-specific immunoglobulin E (IgE) reagents essential for allergy testing and management across the San Antonio military treatment facility and 153 additional military healthcare installations. The reagent supply supports critical diagnostic capabilities...
- The Defense Health Agency awarded a $14,983.68 Blanket Purchase Agreement (BPA) call to Phadia US Inc.'s Immunodiagnostics Division on January 17, 2026, for test and measurement supplies for medical laboratory use. The contract, which carries a firm fixed price structure with no set-aside designation, will be performed in Portage, Michigan, and is scheduled for completion by September 30, 2026. Phadia US Inc., a foreign-owned subsidiary of Thermo Fisher Scientific, specializes in advanced...
- This is a firm-fixed-price BPA call order awarded by the U.S. Army Medical Command (MEDCOM) to Phadia US Inc., a subsidiary of Thermo Fisher Scientific. The contract, valued at $600,000.00, is for allergy and asthma testing products and services to support military medical readiness and research programs. Phadia has received multiple prime federal contracts from agencies such as the Defense Health Agency and Department of the Air Force for its proprietary IMMUNOCAP SYSTEM ANALYZERS and related...